China Health Group Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Health Group Inc with three other
miscellaneous service companies in Asia:
sales of 957.64 million Japanese Yen [US$8.42 million]
of which 54%
was Cell Therapy Technology Development Busi),
SanBio Co Ltd
(949.54 million Japanese Yen [US$8.35 million]
of which 100%
was Commercial Physical Research), and
Naturalendo Tech Co Ltd
based in South Korea
(9.24 billion Korean Won [US$8.17 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
China Health Group Inc were HK$67.70 million (US$8.64 million).
increase of 186.7%
versus 2016, when the company's sales were HK$23.61 million.